• Top Picks
    • MPN Updates
    • Obesity and Comorbidities: Improving Clinical Management and Patient Outcomes in Obesity, Diabetes and Cancer
    • Enhancing Patient and Health Care Team Communications: Paving the way for success
    • Molecular Testing as the Basis for Targeted Therapies in NSCLC

Select a Topic

  • FILTER BY:
  • All Education Lab
  • CME Only
Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates
CME

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Expiration Date: 8/15/2015
Credit Type(s): CME | Credit: 1

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in development, with the hope of dramatically improving outcomes for patients…

go to activity»
Applying Imaging, Biomarkers, and Immunotherapy in the Management of NSCLC
CME

Applying Imaging, Biomarkers, and Immunotherapy in the Management of NSCLC

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 8/6/2015
Credit Type(s): CME | Credit: 1

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, but the numerous subtypes make this disease challenging to accurately diagnose and manage. Careful technique is necessary to…

go to activity»
MPN Updates

MPN Updates

This electronic newsletter is sponsored by Incyte Corp. through a third-party independent grant.

January 8, 2014

As the standards of care for patients with myeloproliferative neoplasms (MPNs) continue to evolve, physicians must stay informed on current research and treatment methods. MPN Updates, a…

go to activity»
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes
CME

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

Expiration Date: 8/15/2015
Credit Type(s): CME | Credit: 1.5

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances have shown that 70% of cases are the result of inherited traits. Hemophilia A,…

go to activity»
Molecular Testing as the Basis for Targeted Therapies in NSCLC
CME

Molecular Testing as the Basis for Targeted Therapies in NSCLC

Supported by an independent educational grant from Boehringer Ingelheim.

Expiration Date: 9/17/2014
Credit Type(s): CME | Credit: 1

NSCLC comprises approximately 85% of all lung cancer cases. NSCLC histologies are primarily adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Certain genetic alterations have allowed…

go to activity»
Obesity and Comorbidities: Improving Clinical Management and Patient Outcomes in Obesity, Diabetes and Cancer
CME

Obesity and Comorbidities: Improving Clinical Management and Patient Outcomes in Obesity, Diabetes and Cancer

This activity is supported by an educational grant from Eisai, Inc.

Expiration Date: 11/13/2014
Credit Type(s): CME | Credit: 0.5

Obesity has increased dramatically in the past 20 years, and is considered a healthcare epidemic in the United States. One-third of adults in the United States are considered obese, having a body…

go to activity»